Å bekjempe kreft er et historisk oppdrag for Norge
Norge kan redusere tiden for utvikling av ny kreftbehandling fra ti til fem år.
Internationalisation and ethics
Students faced great philosophical questions about vaccine distribution.
Bridging gaps at NLSDays 2021
We participated in the first digital NLSDays this week.
Granted PDT/PCI projects 2021
Radforsk Investment Foundation has granted five research projects a total amount of NOK 4,95 million to further develop exciting research projects within photodynamic treatment and photochemical internalization. Cancer researcher Pål Selbo receives NOK 3,75 million for his project. Radforsk Investment Foundation is an evergreen investor focusing on companies that develop cancer treatment. “Radforsk has invested […]
Innspill til Perspektivmeldingen
Oslo Cancer Cluster har uttalt seg om Perspektivmeldingen 2021.
Lytix Biopharma and UiT with exclusive agreement
Lytix Biopharma enters into an exclusive license agreement with the Arctic University of Norway (UiT).
